1,737 filings
Page 10 of 87
6-K
AZN
Astrazeneca plc
1 Dec 22
Block Listing Interim Review
11:05am
6-K
AZN
Astrazeneca plc
30 Nov 22
Astrazeneca Announces Sale of West Chester Site
6:05am
6-K
AZN
Astrazeneca plc
29 Nov 22
Astrazeneca to Acquire Neogene Therapeutics
6:46am
6-K
AZN
Astrazeneca plc
23 Nov 22
Director/pdmr Shareholding
10:40am
6-K
AZN
Astrazeneca plc
14 Nov 22
Enhertu Recommended for Eu Approval In Gastric
6:58am
6-K
AZN
Astrazeneca plc
14 Nov 22
Imfinzi Recommended for Approval In the Eu for BTC
6:58am
6-K
AZN
Astrazeneca plc
14 Nov 22
Lynparza Combo Recommended In the Eu for MCRPC
6:54am
6-K
AZN
Astrazeneca plc
14 Nov 22
Imfinzi + Imjudo Approved In Us for Lung Cancer
6:07am
6-K
AZN
Astrazeneca plc
10 Nov 22
Ytd and Q3 2022 Results
7:00am
6-K
AZN
Astrazeneca plc
9 Nov 22
Fda Advisory Committee Recommends PT027 In Asthma
6:41am
6-K
AZN
Astrazeneca plc
4 Nov 22
Beyfortus (Nirsevimab) Approved In Eu
8:50am
6-K
AZN
Astrazeneca plc
1 Nov 22
Total Voting Rights
11:54am
6-K
AZN
Astrazeneca plc
26 Oct 22
Capivasertib Phase III Trial Met Primary Endpoints
7:15am
6-K
AZN
Astrazeneca plc
25 Oct 22
Update on Messina Phase III Trial
6:31am
6-K
AZN
Astrazeneca plc
24 Oct 22
Imfinzi + Imjudo Approved In Advanced Liver Cancer
7:01am
6-K
AZN
Astrazeneca plc
3 Oct 22
Total Voting Rights
11:55am
6-K
AZN
Astrazeneca plc
30 Sep 22
Board Committee Changes
6:24am
6-K
AZN
Astrazeneca plc
27 Sep 22
Koselugo Approved In Japan for NF1
6:05am
6-K
AZN
Astrazeneca plc
27 Sep 22
Tezspire Approved In Japan for Severe Asthma
6:00am
6-K
AZN
Astrazeneca plc
23 Sep 22
Ultomiris Approved In Eu for GMG
6:01am